의료용 외골격 시장 : 구성요소별, 유형별, 사지별, 양식별, 구조별, 용도별 - 세계 예측(2024-2032년)

Global Medical Exoskeleton Market size will expand at 30.6% CAGR from 2024 to 2032, due to the increasing partnership efforts to launch innovative technologies. Companies are joining forces to integrate advanced engineering and medical expertise to enhance mobility solutions for patients. These collaborations are focused on developing next-generation exoskeletons to offer improved functionality and user experience.

Advancements in sensor technology, AI, and ergonomic design are also enhancing mobility support and rehabilitation outcomes. Rising emphasis on advancing medical exoskeletons as integral tools in enhancing quality of life and independence for individuals with mobility challenges will add to the industry growth. For instance, in October 2023, Wandercraft launched its mobility exoskeleton, Atalante X in the U.S. in partnership with the Kessler Foundation to transform mobility assistance for individuals with mobility impairments through advanced exoskeleton technology.

The market is segregated into component, type, extremities, modality, structure, application, and region.

In terms of component, the software segment in the medical exoskeleton industry is set to experience significant CAGR through 2032. The software used in medical exoskeletons is helping to enhance user interaction and functionality. These components are enabling real-time adjustments and data analysis to optimize movement and support for users with mobility impairments. With technology advances, software updates are enhancing user comfort, safety, and the overall mobility assistance for ensuring that medical exoskeletons remain at the forefront of rehabilitation and mobility solutions for diverse patient needs.

By application, the medical exoskeleton market from the stroke segment is projected to rise from 2024 to 2032 due to rising need for offering support and assistance to individuals recovering from stroke-related impairments. Medical exoskeleton devices are utilizing advanced technologies to facilitate movement and improve mobility for stroke survivors during therapy sessions. Rising integration with biofeedback mechanisms and adaptive algorithms to enhance rehabilitation outcomes will drive the segment growth.

Regionally, the Asia Pacific medical exoskeleton industry size is projected to depict robust growth between 2024 and 2032. The aging population and increasing incidence of disabilities are driving the demand for advanced mobility solutions that can assist individuals with mobility impairments caused by aging-related conditions and disabilities. Innovations in medical exoskeleton technologies are enhancing usability, comfort, and effectiveness in aiding mobility for elderly and disabled individuals. The ongoing advancements in medical exoskeletons for improving quality of life and mobility support for the diverse population facing mobility challenges in Asia Pacific will add to the market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing patient population with physical disabilities
    • 3.2.1.2 Rising prevalence of neurological diseases and injuries
    • 3.2.1.3 Technological advancements in products
    • 3.2.1.4 Rise in number of orthopedic surgeries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High product cost and regulatory challenges
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technological landscape
• 3.7 Start-up scenario
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Components, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hardware
  • 5.2.1 Sensors
    • 5.2.1.1 Gyroscopes
    • 5.2.1.2 Accelerometers
    • 5.2.1.3 Other sensors
  • 5.2.2 Actuators
    • 5.2.2.1 Pneumatic actuator
    • 5.2.2.2 Hydraulic actuator
    • 5.2.2.3 Electric actuator
  • 5.2.3 Power sources
  • 5.2.4 Control systems
  • 5.2.5 Other hardware components
• 5.3 Software

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Powered
• 6.3 Passive

Chapter 7 Market Estimates and Forecast, By Extremities, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Lower
• 7.3 Upper
• 7.4 Full body

Chapter 8 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Mobile
• 8.3 Stationary

Chapter 9 Market Estimates and Forecast, By Structure, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Soft exoskeleton
• 9.3 Rigid exoskeleton

Chapter 10 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 Spinal cord injury
• 10.3 Stroke
• 10.4 Other applications

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Italy
  • 11.3.5 Spain
  • 11.3.6 Netherlands
  • 11.3.7 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 India
  • 11.4.3 Japan
  • 11.4.4 Australia
  • 11.4.5 South Korea
  • 11.4.6 Rest of Asia Pacific
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
  • 11.5.4 Rest of Latin America
• 11.6 Middle East and Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 South Africa
  • 11.6.3 UAE
  • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

• 12.1 B-Temia
• 12.2 CYBERDYNE INC.
• 12.3 Ekso Bionics
• 12.4 ExoAtlet
• 12.5 Hocoma
• 12.6 Honda Motor Co., Ltd.
• 12.7 PARKER HANNIFIN CORP
• 12.8 ReWalk Robotics
• 12.9 Rex Bionics Ltd.
• 12.10 Suit X
• 12.11 Wearable Robotics srl